News | March 06, 2023
Neogen Chemicals to acquire 100% stake in BuLi Chemicals India from Livent
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
The marketing authorisations for three generic drugs signifying advances in cancer treatment will considerably benefit thousands of patients by improving access, ensuring affordability
IAGES to focus on upskilling and adoption of advanced Minimal Access Surgery technologies in 2023
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
Strategic partnership aims to support significant growth of the Ibuprofen product market in Brazil and is backed by Univar Solutions' state-of-the-art Solution Center in São Paulo, Brazil
Profit after Tax stood at Rs. 106 crore as compared to Rs. 84 crore registering growth of 26%
It will help upgrade the infrastructure and technologies of the country's biopharmaceuticals and in-vitro diagnostic industry
The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22
Subscribe To Our Newsletter & Stay Updated
